Director, CEO · TENAX THERAPEUTICS, INC. · Common Stock
Side
BUY
Value
$4,083
Shares
538
Price
$7.59
Executed
Nov 20, 2025
Disclosed
Nov 20, 2025
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Nov 20 executedNov 20, 2025 disclosed
TENX · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 0 business days after execution (deadline: 2)
Historical behavior+4 / 15
2 prior trades recorded in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Giordano Christopher Thomas filed this Form 4 reporting a open-market purchase of TENX on Nov 20, 2025. It became public on Nov 20, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, CEO
Giordano Christopher Thomascik:0001871714
Issuer
TENAX THERAPEUTICS, INC.cik:0000034956
Revision history · 0
No field has changed since this record was first ingested.
